2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Chmela Z, Veselý J, Lemr K, Rypka M, Hanuš J, Havlíček L, Kryštof V, Michnová L, Fuksová K, Lukeš J:
In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route.
Drug Metab Dispos 29, 326-334, 2001.
Franěk F, Strnad M, Havlíček L, Siglerová V, Fismolová I, Eckschlager T: Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture. Cytotechnology 36, 117-123, 2001.
Horký M, Wurzer G, Kotala V, Anton M, Vojtěšek B, Vácha J, Wesierska-Gadek J:
Segregation of nucleolar components coincides with caspase-3 activation in cisplatin-treated HeLa cells.
J Cell Sci 114, 663-70, 2001.
Kryštof V, Strnad M:
Inhibitors of Cyclin-dependent Kinases.
Chem listy 95, 295-300, 2001.
Kotala V, Uldrijan S, Horký M, Trbušek M, Strnad M, Vojtěšek B:
Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases.
Cell Mol Life Sci 58, 1333-1339, 2001.
Maloň M, Trávníček Z, Maryško M, Zbořil R, Mašláň M, Marek J, Doležal K, Rolčík J, Kryštof V, Strnad M:
Metal complexes as anticancer agent 2. Iron(III) and copper(II) bio-active complexes with benzylaminopurine derivatives.
Inorg Chim Acta 323, 119-129, 2001.
Trávníček Z, Maloň M, Šindelář Z, Doležal K, Rolčík J, Kryštof V, Strnad M, Marek J:
Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure of [Cu(H+L2)2Cl3]Cl·2H2O.
J Inorg Biochem 84, 23-32, 2001.
Werner T, Motyka V, Strnad M, Schmulling T:
Regulation of plant growth by cytokinin.
Proc Natl Acad Sci USA 98, 10487-10492, 2001.